Predict your next investment

Caris Life Sciences company logo
Corporation
HEALTHCARE | Biotechnology
carislifesciences.com

See what CB Insights has to offer

Total Raised

$1.314B

Investors Count

17

Deal Terms

3

Caris Life Sciences Funding, Caris Life Sciences Valuation & Caris Life Sciences Revenue

8 Fundings

Caris Life Sciences's latest funding round was a Private Equity - II for $830M on May 12, 2021.

Caris Life Sciences's latest post-money valuation is from May 2021.

Sign up for a free 30-day trial to see Caris Life Sciences's valuations in May 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/12/2021

Private Equity - II

$830M

$99M

$0.00B

((9.99x))

FY 1234

2

10/27/2020

Debt - II

$99M

$0.00B

((9.99x))

FY 1234

10

10/27/2020

Private Equity

$99M

$0.00B

((9.99x))

FY 1234

10

10/1/2018

Convertible Note

$99M

$0.00B

((9.99x))

FY 1234

10

10/1/2018

Debt

$99M

$0.00B

((9.99x))

FY 1234

10

Date

5/12/2021

10/27/2020

10/27/2020

10/1/2018

10/1/2018

Round

Private Equity - II

Debt - II

Private Equity

Convertible Note

Debt

Amount

$830M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

2

10

10

10

10

Caris Life Sciences Deal Terms

3 Deal Terms

Caris Life Sciences's deal structure is available for 3 funding rounds, including their Private Equity - II from May 12, 2021.

Round

Private Equity - II

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Private Equity - II

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Series A

Caris Life Sciences Investors

17 Investors

Caris Life Sciences has 17 investors. Sixth Street Partners invested in Caris Life Sciences's Private Equity - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/1/2018

5/12/2021

5
Convertible Note, Debt (2018), Private Equity (2020), Debt - II (2020), Private Equity - II (2021)

Diversified Financial Services

California

10/27/2020

5/12/2021

2
Private Equity, Private Equity - II (2021)

Asset/Investment Management

Minnesota

10/27/2020

5/12/2021

2
Private Equity, Private Equity - II (2021)

Asset/Investment Management

New York

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Asset/Investment Management

New York

First funding

10/1/2018

10/27/2020

10/27/2020

00/00/0000

00/00/0000

Last Funding

5/12/2021

5/12/2021

5/12/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

5
Convertible Note, Debt (2018), Private Equity (2020), Debt - II (2020), Private Equity - II (2021)
2
Private Equity, Private Equity - II (2021)
2
Private Equity, Private Equity - II (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Diversified Financial Services

Asset/Investment Management

Asset/Investment Management

Venture Capital

Asset/Investment Management

Location

California

Minnesota

New York

New York

New York

Caris Life Sciences Acquisitions

1 Acquisition

Caris Life Sciences acquired 1 company. Their latest acquisition was Pharmatech on May 01, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/1/2019

Acquired

1

Date

5/1/2019

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.